Kessler Topaz Meltzer & Check, LLP Reminds Cardiovascular Systems, Inc. Shareholders of Class Action Lawsuit
February 24 2016 - 11:08AM
Business Wire
The law firm of Kessler Topaz Meltzer & Check, LLP reminds
Cardiovascular Systems, Inc. (NASDAQ: CSII) (“CSI” or the
“Company”) shareholders that a class action lawsuit has been filed
on behalf of purchasers of the Company’s securities between
September 12, 2011 and January 21, 2016, inclusive (the “Class
Period”).
Shareholders who wish to discuss this action and their legal
options are encouraged to contact Kessler Topaz Meltzer &
Check, LLP (Darren J. Check, Esq. or D. Seamus Kaskela, Esq.) at
(888) 299-7706 or at info@ktmc.com. For additional information
about this lawsuit, or to request information about this action
online, please visit
https://www.ktmc.com/new-cases/cardiovascular-systems-inc.
CSI is a medical technology company that develops, manufactures,
and markets devices to treat vascular diseases, such as Peripheral
Arterial Disease (“PAD”).
The shareholder class action complaint alleges that CSI and
certain of its executive officers made a series of false and
misleading statements to investors and failed to disclose material
adverse facts about the Company’s business, operations, and
prospects. Specifically, the defendants are alleged to have made
materially false and misleading statements to investors and/or
failed to disclose that: (1) CSI distributed illegal kickbacks to
health care providers; (2) CSI engaged in the off-label promotion
of its medical devices; and (3) CSI violated the Food and Drug
Administration’s laws and regulations in connection with its
medical devices.
Reminder: CSI shareholders who purchased their securities
during the Class Period may, no later than April 12, 2016, petition
the Court to be appointed as a lead plaintiff representative of the
class.
Members of the purported class may petition the Court to be
appointed as a lead plaintiff through Kessler Topaz Meltzer &
Check or other counsel, or may choose to do nothing and remain an
absent class member. A lead plaintiff is a representative party who
acts on behalf of other class members in directing the litigation.
In order to be appointed as a lead plaintiff, the Court must
determine that the class member’s claim is typical of the claims of
other class members, and that the class member will adequately
represent the class in the action. Your ability to share in any
recovery is not affected by the decision of whether or not to serve
as a lead plaintiff.
Kessler Topaz Meltzer & Check prosecutes class actions in
state and federal courts throughout the country. Kessler Topaz
Meltzer & Check is a driving force behind corporate governance
reform, and has recovered billions of dollars on behalf of
institutional and individual investors from the United States and
around the world. The complaint in this action was not filed by
Kessler Topaz Meltzer & Check. For more information about
Kessler Topaz Meltzer & Check please visit www.ktmc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160224006041/en/
Kessler Topaz Meltzer & Check, LLPDarren J. Check, Esq.D.
Seamus Kaskela, Esq.888-299-7706
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2023 to Jul 2024